{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:25:36Z","timestamp":1792167936708,"version":"4.4.0"},"reference-count":172,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Asthma is defined as a chronic respiratory disease, the processes of which are mainly related to the hyperreactivity of the immune system. Airway hyperresponsiveness and remodeling are other hallmarks of asthma that are strongly involved in the progression of the disease. Moreover, asthma is associated with the occurrence of atopic dermatitis, chronic sinusitis, allergic rhinitis, and a high profile of T2-type cytokines, such as IL-4, IL-5 and IL-13. The hyperresponsiveness of the immune system is a consequence of aberrant levels of alarmins, endogenous molecules that induce pro-inflammatory responses. They are released as a result of a defect or cell death, leading to the initiation of an inflammatory reaction. High-mobility group box 1 (HMGB1), S100 proteins, interleukin-33 (IL-33), thymic stromal lymphopoietin (TSLP), and IL-25 bind to various receptors, influencing the behavior of immune cells, resulting in stimulated migration and activation of these cells. In this review, we will discuss the potential role of alarmins in the pathogenesis of asthma.<\/jats:p>","DOI":"10.3390\/biom15070996","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T15:19:31Z","timestamp":1752247171000},"page":"996","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Role of Alarmins in the Pathogenesis of Asthma"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6821-0086","authenticated-orcid":false,"given":"Paulina","family":"Plewa","sequence":"first","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Pokwicka","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estera","family":"Bakinowska","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8227-6753","authenticated-orcid":false,"given":"Kajetan","family":"Kie\u0142bowski","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6557-1208","authenticated-orcid":false,"given":"Andrzej","family":"Pawlik","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(22)02125-0","article-title":"Asthma","volume":"401","author":"Porsbjerg","year":"2023","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"16250","DOI":"10.20452\/pamw.16250","article-title":"Asthma and comorbidities: Recent advances","volume":"132","author":"Cazzola","year":"2022","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","article-title":"Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease","volume":"56","author":"Kuruvilla","year":"2019","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2500\/aap.2022.43.220047","article-title":"Clinical implications of asthma endotypes and phenotypes","volume":"43","author":"Taunk","year":"2022","journal-title":"Allergy Asthma Proc."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Popovi\u0107-Grle, S., \u0160tajduhar, A., Lampalo, M., and Rnjak, D. (2021). Biomarkers in Different Asthma Phenotypes. Genes, 12.","DOI":"10.3390\/genes12060801"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ricciardolo, F.L.M., Sprio, A.E., Baroso, A., Gallo, F., Riccardi, E., Bertolini, F., Carriero, V., Arrigo, E., and Ciprandi, G. (2021). Characterization of T2-Low and T2-High Asthma Phenotypes in Real-Life. Biomedicines, 9.","DOI":"10.3390\/biomedicines9111684"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pop.2023.01.001","article-title":"Management of Chronic Asthma in Adults","volume":"50","author":"Nguyen","year":"2023","journal-title":"Prim. Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/all.14425","article-title":"EAACI Biologicals Guidelines-Recommendations for severe asthma","volume":"76","author":"Agache","year":"2021","journal-title":"Allergy"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/imr.12577","article-title":"Alarmins and immunity","volume":"280","author":"Yang","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0306164","article-title":"DAMPs, PAMPs and alarmins: All we need to know about danger","volume":"81","author":"Bianchi","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8995","DOI":"10.3390\/cimb46080532","article-title":"The Role of Alarmins in the Pathogenesis of Atherosclerosis and Myocardial Infarction","volume":"46","author":"Kielbowski","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.3390\/cimb46040228","article-title":"The Role of Alarmins in the Pathogenesis of Rheumatoid Arthritis, Osteoarthritis, and Psoriasis","volume":"46","author":"Kielbowski","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.immuni.2024.09.001","article-title":"Alarmin-loaded extracellular lipid droplets induce airway neutrophil infiltration during type 2 inflammation","volume":"57","author":"Rao","year":"2024","journal-title":"Immunity"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1164\/rccm.202009-3686OC","article-title":"Targeting the P2Y(13) Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental Asthma","volume":"205","author":"Werder","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma--present in most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1164\/rccm.202305-0808OC","article-title":"Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma","volume":"209","author":"Wechsler","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41556-021-00762-2","article-title":"Eosinophil extracellular traps drive asthma progression through neuro-immune signals","volume":"23","author":"Lu","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-021-00482-x","article-title":"Eosinophil-derived chemokine (hCCL15\/23, mCCL6) interacts with CCR1 to promote eosinophilic airway inflammation","volume":"6","author":"Du","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/all.13997","article-title":"Eosinophil extracellular traps activate type 2 innate lymphoid cells through stimulating airway epithelium in severe asthma","volume":"75","author":"Choi","year":"2020","journal-title":"Allergy"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"156091","DOI":"10.1016\/j.cyto.2022.156091","article-title":"IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline","volume":"162","author":"Scott","year":"2023","journal-title":"Cytokine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e70010","DOI":"10.1111\/imr.70010","article-title":"Chronic Inflammation in Asthma: Looking Beyond the Th2 Cell","volume":"330","author":"Olsthoorn","year":"2025","journal-title":"Immunol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Cheema, N.A., Castagna, A., Ambrosani, F., Argentino, G., Friso, S., Zurlo, M., Beri, R., Maule, M., Vaia, R., and Senna, G. (2025). Extracellular Vesicles in Asthma: Intercellular Cross-Talk in TH2 Inflammation. Cells, 14.","DOI":"10.3390\/cells14070542"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e2320727121","DOI":"10.1073\/pnas.2320727121","article-title":"A distal enhancer of GATA3 regulates Th2 differentiation and allergic inflammation","volume":"121","author":"Kumagai","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacig.2022.07.007","article-title":"Upregulation of IL-4 receptor signaling pathway in circulating ILC2s from asthma patients","volume":"1","author":"Baba","year":"2022","journal-title":"J. Allergy Clin. Immunol. Glob."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/13543784.2023.2215425","article-title":"Investigational anti IL-13 asthma treatments: A 2023 update","volume":"32","author":"Matera","year":"2023","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MCP.0000000000001154","article-title":"Non-T2 asthma","volume":"31","author":"Duffus","year":"2025","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1432-1033.1973.tb03188.x","article-title":"Isolation and characterisation of two calf-thymus chromatin non-histone proteins with high contents of acidic and basic amino acids","volume":"40","author":"Goodwin","year":"1973","journal-title":"Eur. J. Biochem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","article-title":"The mechanism of HMGB1 secretion and release","volume":"54","author":"Chen","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"156171","DOI":"10.1016\/j.cyto.2023.156171","article-title":"HMGB1 is a promising therapeutic target for asthma","volume":"165","author":"Zhao","year":"2023","journal-title":"Cytokine"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Furci, F., Murdaca, G., Pelaia, C., Imbalzano, E., Pelaia, G., Caminati, M., Allegra, A., Senna, G., and Gangemi, S. (2023). TSLP and HMGB1: Inflammatory Targets and Potential Biomarkers for Precision Medicine in Asthma and COPD. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020437"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13045-020-00920-3","article-title":"High mobility group box 1 (HMGB1): A pivotal regulator of hematopoietic malignancies","volume":"13","author":"Yuan","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1089\/ars.2019.7818","article-title":"The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases","volume":"31","author":"Wang","year":"2019","journal-title":"Antioxid. Redox Signal"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"172487","DOI":"10.1016\/j.ejphar.2019.172487","article-title":"Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling","volume":"858","author":"Paudel","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1189\/jlb.72.6.1084","article-title":"HMGB1 as a DNA-binding cytokine","volume":"72","author":"Andersson","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1053\/rmed.2001.1162","article-title":"Expression of matrix metalloproteinases MMP-9 within the airways in asthma","volume":"97","author":"Han","year":"2003","journal-title":"Respir. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1083\/jcb.200911078","article-title":"Endogenous HMGB1 regulates autophagy","volume":"190","author":"Tang","year":"2010","journal-title":"J. Cell Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cyto.2014.03.007","article-title":"How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1","volume":"69","author":"Keyel","year":"2014","journal-title":"Cytokine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e1124","DOI":"10.1002\/iid3.1124","article-title":"High-mobility group box 1 emerges as a therapeutic target for asthma","volume":"11","author":"Yang","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_39","first-page":"5527","article-title":"Effects of mimicked acetylated HMGB1 on macrophages and dendritic cells","volume":"18","author":"Chen","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.molimm.2013.07.008","article-title":"RAGE and TLRs: Relatives, friends or neighbours?","volume":"56","author":"Ibrahim","year":"2013","journal-title":"Mol. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/all.14600","article-title":"The axis of the receptor for advanced glycation endproducts in asthma and allergic airway disease","volume":"76","author":"Perkins","year":"2021","journal-title":"Allergy"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2387100","DOI":"10.1080\/08916934.2024.2387100","article-title":"Astragaloside IV promotes the pyroptosis of airway smooth muscle cells in childhood asthma by suppressing HMGB1\/RAGE axis to inactivate NF-\u03bab pathway","volume":"57","author":"Zhang","year":"2024","journal-title":"Autoimmunity"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.rmed.2010.10.016","article-title":"Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients","volume":"105","author":"Watanabe","year":"2011","journal-title":"Respir. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1189\/jlb.0306180","article-title":"High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin","volume":"81","author":"Yang","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1097\/CM9.0000000000002491","article-title":"High mobility group box 1 levels as potential predictors of asthma severity","volume":"136","author":"Xu","year":"2023","journal-title":"Chin. Med. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2500\/aap.2017.38.4047","article-title":"High mobility group box 1: Biomarker of inhaled corticosteroid treatment response in children with moderate-severe asthma","volume":"38","author":"Manti","year":"2017","journal-title":"Allergy Asthma Proc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"113753","DOI":"10.1016\/j.intimp.2024.113753","article-title":"Mechanism of action of miR-15b-5p in alleviating asthma airway remodeling through the HMGB1\/TLR4\/IL-33 signaling axis","volume":"145","author":"Liu","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1365-2222.2012.03998.x","article-title":"The role of high-mobility group box-1 (HMGB1) in the pathogenesis of asthma","volume":"42","author":"Shim","year":"2012","journal-title":"Clin. Exp. Allergy"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2567.2004.01906.x","article-title":"Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils","volume":"112","author":"Stenfeldt","year":"2004","journal-title":"Immunology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaci.2019.06.012","article-title":"RAGE-induced asthma: A role for the receptor for advanced glycation end-products in promoting allergic airway disease","volume":"144","author":"Brandt","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2174\/0115665240249953231024060610","article-title":"HMGB1\/RAGE Signaling Regulates Th17\/IL-17 and Its Role in Bronchial Epithelial-Mesenchymal Transformation","volume":"24","author":"Sun","year":"2024","journal-title":"Curr. Mol. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11010-015-2396-0","article-title":"HMGB1 binding to receptor for advanced glycation end products enhances inflammatory responses of human bronchial epithelial cells by activating p38 MAPK and ERK1\/2","volume":"405","author":"Liang","year":"2015","journal-title":"Mol. Cell Biochem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1194\/jlr.R600021-JLR200","article-title":"The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk","volume":"48","author":"Popa","year":"2007","journal-title":"J. Lipid Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2222.2003.01576.x","article-title":"Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients","volume":"33","author":"Asai","year":"2003","journal-title":"Clin. Exp. Allergy"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.4049\/jimmunol.181.4.2790","article-title":"Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease","volume":"181","author":"Ying","year":"2008","journal-title":"J. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.humimm.2012.08.016","article-title":"HMGB1 and RAGE levels in induced sputum correlate with asthma severity and neutrophil percentage","volume":"73","author":"Zhou","year":"2012","journal-title":"Hum. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11882-001-0080-9","article-title":"The bronchial epithelium in chronic and severe asthma","volume":"1","author":"Davies","year":"2001","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Yamasaki, A., Okazaki, R., and Harada, T. (2022). Neutrophils and Asthma. Diagnostics, 12.","DOI":"10.3390\/diagnostics12051175"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Chang, J., Xia, Y., Wasserloos, K., Deng, M., Blose, K.J., Vorp, D.A., Turnquist, H.R., Billiar, T.R., Pitt, B.A., and Zhang, M.Z. (2017). Cyclic stretch induced IL-33 production through HMGB1\/TLR-4 signaling pathway in murine respiratory epithelial cells. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0184770"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.intimp.2016.06.010","article-title":"HMGB1 regulates IL-33 expression in acute respiratory distress syndrome","volume":"38","author":"Fu","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.bcp.2013.08.003","article-title":"Inhibition of high-mobility group box 1 in lung reduced airway inflammation and remodeling in a mouse model of chronic asthma","volume":"86","author":"Lee","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1039\/c9tx00048h","article-title":"Inhibitions of HMGB1 and TLR4 alleviate DINP-induced asthma in mice","volume":"8","author":"Hwang","year":"2019","journal-title":"Toxicol. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/cmi.2014.60","article-title":"HMGB1 contributes to allergen-induced airway remodeling in a murine model of chronic asthma by modulating airway inflammation and activating lung fibroblasts","volume":"12","author":"Hou","year":"2015","journal-title":"Cell Mol. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.intimp.2014.04.024","article-title":"Ethyl pyruvate decreases airway neutrophil infiltration partly through a high mobility group box 1-dependent mechanism in a chemical-induced murine asthma model","volume":"21","author":"Tang","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"ref_65","first-page":"2915","article-title":"Vitamin D reduces inflammatory response in asthmatic mice through HMGB1\/TLR4\/NF-\u03baB signaling pathway","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0006-291X(65)90320-7","article-title":"A soluble protein characteristic of the nervous system","volume":"19","author":"Moore","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5488591","DOI":"10.1155\/2021\/5488591","article-title":"The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases","volume":"2021","author":"Sattar","year":"2021","journal-title":"Pulm. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-4939-9030-6_18","article-title":"S100 Proteins in the Innate Immune Response to Pathogens","volume":"1929","author":"Kozlyuk","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Gonzalez, L.L., Garrie, K., and Turner, M.D. (2020). Role of S100 proteins in health and disease. Biochim. Biophys. Acta Mol. Cell Res., 1867.","DOI":"10.1016\/j.bbamcr.2020.118677"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.bbrc.2004.07.096","article-title":"S100 proteins in mouse and man: From evolution to function and pathology (including an update of the nomenclature)","volume":"322","author":"Marenholz","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Singh, P., and Ali, S.A. (2022). Multifunctional Role of S100 Protein Family in the Immune System: An Update. Cells, 11.","DOI":"10.3390\/cells11152274"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Cer\u00f3n, J.J., Ort\u00edn-Bustillo, A., L\u00f3pez-Mart\u00ednez, M.J., Mart\u00ednez-Subiela, S., Eckersall, P.D., Tecles, F., Tvarijonaviciute, A., and Mu\u00f1oz-Prieto, A. (2023). S-100 Proteins: Basics and Applications as Biomarkers in Animals with Special Focus on Calgranulins (S100A8, A9, and A12). Biology, 12.","DOI":"10.3390\/biology12060881"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s11427-016-5088-4","article-title":"Binding of transition metals to S100 proteins","volume":"59","author":"Gilston","year":"2016","journal-title":"Sci. China Life Sci."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Wheeler, L.C., Donor, M.T., Prell, J.S., and Harms, M.J. (2016). Multiple Evolutionary Origins of Ubiquitous Cu2+ and Zn2+ Binding in the S100 Protein Family. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0164740"},{"key":"ref_75","first-page":"198","article-title":"S100 protein family and its application in clinical practice","volume":"12","author":"Sedaghat","year":"2008","journal-title":"Hippokratia"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ceca.2012.11.006","article-title":"Evolution of the S100 family of calcium sensor proteins","volume":"53","author":"Zimmer","year":"2013","journal-title":"Cell Calcium"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Schenten, V., Plan\u00e7on, S., Jung, N., Hann, J., Bueb, J.L., Br\u00e9chard, S., Tschirhart, E.J., and Tolle, F. (2018). Secretion of the Phosphorylated Form of S100A9 from Neutrophils Is Essential for the Proinflammatory Functions of Extracellular S100A8\/A9. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00447"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Sprenkeler, E.G.G., Zandstra, J., van Kleef, N.D., Goetschalckx, I., Verstegen, B., Aarts, C.E.M., Janssen, H., Tool, A.T.J., van Mierlo, G., and van Bruggen, R. (2022). S100A8\/A9 Is a Marker for the Release of Neutrophil Extracellular Traps and Induces Neutrophil Activation. Cells, 11.","DOI":"10.3390\/cells11020236"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/s12276-021-00652-5","article-title":"S100A9 in adult asthmatic patients: A biomarker for neutrophilic asthma","volume":"53","author":"Quoc","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/tox.23776","article-title":"Secreted S100A4 causes asthmatic airway epithelial barrier dysfunction induced by house dust mite extracts via activating VEGFA\/VEGFR2 pathway","volume":"38","author":"Huang","year":"2023","journal-title":"Environ. Toxicol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"111555","DOI":"10.1016\/j.intimp.2024.111555","article-title":"S100A4 reprofiles lipid metabolism in mast cells via RAGE and PPAR-\u03b3 signaling pathway","volume":"128","author":"Shihui","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"L185","DOI":"10.1152\/ajplung.00347.2019","article-title":"S100A4 is secreted by airway smooth muscle tissues and activates inflammatory signaling pathways via receptors for advanced glycation end products","volume":"319","author":"Wu","year":"2020","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e730","DOI":"10.1002\/iid3.730","article-title":"The miR-124-3p regulates the allergic airway inflammation and remodeling in an ovalbumin-asthmatic mouse model by inhibiting S100A4","volume":"11","author":"Liu","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Wu, T., Ma, L., Jin, X., He, J., Chen, K., Zhang, D., Yuan, R., Yang, J., Zhong, Q., and Zhou, H. (2021). S100A4 Is Critical for a Mouse Model of Allergic Asthma by Impacting Mast Cell Activation. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.692733"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11596-022-2559-7","article-title":"Inhibitory Effect of S100A11 on Airway Smooth Muscle Contraction and Airway Hyperresponsiveness","volume":"42","author":"Cheng","year":"2022","journal-title":"Curr. Med. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1164\/rccm.200703-409OC","article-title":"Sputum proteomics in inflammatory and suppurative respiratory diseases","volume":"178","author":"Gray","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.clim.2017.08.013","article-title":"Role of S100A9 in the development of neutrophilic inflammation in asthmatics and in a murine model","volume":"183","author":"Lee","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/cea.13265","article-title":"Monocytes accumulate in the airways of children with fatal asthma","volume":"48","author":"Malmstrom","year":"2018","journal-title":"Clin. Exp. Allergy"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2222.2008.03186.x","article-title":"Expression profiling of genes related to asthma exacerbations","volume":"39","author":"Aoki","year":"2009","journal-title":"Clin. Exp. Allergy"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jaci.2014.09.011","article-title":"Fibrocyte trafficking in patients with chronic obstructive asthma and during an acute asthma exacerbation","volume":"135","author":"Wang","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaci.2006.08.021","article-title":"S100A12 provokes mast cell activation: A potential amplification pathway in asthma and innate immunity","volume":"119","author":"Yang","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"102148","DOI":"10.1016\/j.pupt.2022.102148","article-title":"Strongyloides venezuelensis-derived venestatin ameliorates asthma pathogenesis by suppressing receptor for advanced glycation end-products-mediated signaling","volume":"75","author":"Tsubokawa","year":"2022","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/14728222.2022.2077723","article-title":"Dapagliflozin mitigates ovalbumin-prompted airway inflammatory-oxidative successions and associated bronchospasm in a rat model of allergic asthma","volume":"26","author":"Tabaa","year":"2022","journal-title":"Expert. Opin. Ther. Targets"},{"key":"ref_94","first-page":"8896108","article-title":"Inhibitory Effect of Paquinimod on a Murine Model of Neutrophilic Asthma Induced by Ovalbumin with Complete Freund\u2019s Adjuvant","volume":"2021","author":"Lee","year":"2021","journal-title":"Can. Respir. J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"9667","DOI":"10.1002\/jcb.28245","article-title":"Elevated S100A4 in asthmatics and an allergen-induced mouse asthma model","volume":"120","author":"Huang","year":"2019","journal-title":"J. Cell Biochem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s12079-018-0464-4","article-title":"A network map of IL-33 signaling pathway","volume":"12","author":"Pinto","year":"2018","journal-title":"J. Cell Commun. Signal."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/imm.13404","article-title":"IL-33 activates mTORC1 and modulates glycolytic metabolism in CD8(+) T cells","volume":"165","author":"Liang","year":"2022","journal-title":"Immunology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.immuni.2023.01.029","article-title":"The alarmin interleukin-33 promotes the expansion and preserves the stemness of Tcf-1(+) CD8(+) T cells in chronic viral infection","volume":"56","author":"Marx","year":"2023","journal-title":"Immunity"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/SHK.0000000000002114","article-title":"The Il-33\/St2 Axis Promotes Acute Respiratory Distress Syndrome by Natural Killer T Cells","volume":"59","author":"Zou","year":"2023","journal-title":"Shock."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.4049\/jimmunol.2300191","article-title":"IL-33 Orchestrated the Interaction and Immunoregulatory Functions of Alternatively Activated Macrophages and Regulatory T Cells In Vitro","volume":"211","author":"Mok","year":"2023","journal-title":"J. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaci.2020.04.051","article-title":"Phenotypic and functional translation of IL33 genetics in asthma","volume":"147","author":"Ketelaar","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"110234","DOI":"10.1016\/j.clim.2024.110234","article-title":"Selective production of IL-33-neutralizing autoantibody ameliorates asthma responses and severity","volume":"264","author":"Ji","year":"2024","journal-title":"Clin. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.rmed.2018.05.016","article-title":"Airway Interleukin-33 and type 2 cytokines in adult patients with acute asthma","volume":"140","author":"Poulsen","year":"2018","journal-title":"Respir. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41419-023-05971-1","article-title":"PTRF-IL33-ZBP1 signaling mediating macrophage necroptosis contributes to HDM-induced airway inflammation","volume":"14","author":"Du","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e20240103","DOI":"10.1084\/jem.20240103","article-title":"Interleukin-33-activated basophils promote asthma by regulating Th2 cell entry into lung tissue","volume":"221","author":"Schuijs","year":"2024","journal-title":"J. Exp. Med."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Wu, M., Zheng, X., Huang, J., and Hu, X. (2021). Association of. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.750382"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/all.15487","article-title":"IL1RAP expression and the enrichment of IL-33 activation signatures in severe neutrophilic asthma","volume":"78","author":"Badi","year":"2023","journal-title":"Allergy"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1038\/s41467-023-40820-x","article-title":"Type-2 CD8(+) T-cell formation relies on interleukin-33 and is linked to asthma exacerbations","volume":"14","author":"Krabbendam","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa2024257","article-title":"Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma","volume":"385","author":"Wechsler","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2021.03.044","article-title":"Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial","volume":"148","author":"Kelsen","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"114897","DOI":"10.1016\/j.intimp.2025.114897","article-title":"Metformin alleviates inflammatory responses in acute allergic asthma by inhibiting ILC2s function","volume":"159","author":"Liu","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_113","first-page":"321","article-title":"A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells","volume":"22","author":"Friend","year":"1994","journal-title":"Exp. Hematol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"bau007","DOI":"10.1093\/database\/bau007","article-title":"TSLP signaling pathway map: A platform for analysis of TSLP-mediated signaling","volume":"2014","author":"Zhong","year":"2014","journal-title":"Database"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1478-811X-6-5","article-title":"Signal transduction around thymic stromal lymphopoietin (TSLP) in atopic asthma","volume":"6","author":"Sebastian","year":"2008","journal-title":"Cell Commun. Signal."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Smolinska, S., Antol\u00edn-Am\u00e9rigo, D., Popescu, F.D., and Jutel, M. (2023). Thymic Stromal Lymphopoietin (TSLP), Its Isoforms and the Interplay with the Epithelium in Allergy and Asthma. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612725"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"14937","DOI":"10.1038\/ncomms14937","article-title":"Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma","volume":"8","author":"Verstraete","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jcmgh.2017.01.005","article-title":"Thymic Stromal Lymphopoietin: To Cut a Long Story Short","volume":"3","author":"Tsilingiri","year":"2017","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.autrev.2016.09.014","article-title":"Insight into the role of TSLP in inflammatory bowel diseases","volume":"16","author":"Park","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jdermsci.2012.03.007","article-title":"Long TSLP transcript expression and release of TSLP induced by TLR ligands and cytokines in human keratinocytes","volume":"66","author":"Xie","year":"2012","journal-title":"J. Dermatol. Sci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.cyto.2012.10.025","article-title":"Expression analysis and specific blockade of the receptor for human thymic stromal lymphopoietin (TSLP) by novel antibodies to the human TSLPR\u03b1 receptor chain","volume":"61","author":"Borowski","year":"2013","journal-title":"Cytokine"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s40265-020-01273-4","article-title":"TSLP Inhibitors for Asthma: Current Status and Future Prospects","volume":"80","author":"Matera","year":"2020","journal-title":"Drugs"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/eji.200939419","article-title":"Thymic stromal lymphopoietin induces early human B-cell proliferation and differentiation","volume":"40","author":"Scheeren","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.20062211","article-title":"Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells","volume":"204","author":"Allakhverdi","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature10329","article-title":"TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation","volume":"477","author":"Siracusa","year":"2011","journal-title":"Nature"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/iid3.20","article-title":"The effects of thymic stromal lymphopoietin and IL-3 on human eosinophil-basophil lineage commitment: Relevance to atopic sensitization","volume":"2","author":"Hui","year":"2014","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1038\/ncomms3847","article-title":"Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade","volume":"4","author":"Hener","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Varricchi, G., Pecoraro, A., Marone, G., Criscuolo, G., Spadaro, G., and Genovese, A. (2018). Thymic Stromal Lymphopoietin Isoforms, Inflammatory Disorders, and Cancer. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01595"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"19455","DOI":"10.1073\/pnas.1008271107","article-title":"Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling","volume":"107","author":"Rochman","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cellimm.2012.10.005","article-title":"Signaling cascades initiated by TSLP-mediated signals in different cell types","volume":"279","author":"Yu","year":"2012","journal-title":"Cell Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/JAA.S275039","article-title":"Targeting TSLP in Asthma","volume":"15","author":"Parnes","year":"2022","journal-title":"J. Asthma Allergy"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Chorvinsky, E., Nino, G., Salka, K., Gaviria, S., Gutierrez, M.J., and Pillai, D.K. (2022). TSLP bronchoalveolar lavage levels at baseline are linked to clinical disease severity and reduced lung function in children with asthma. Front. Pediatr., 10.","DOI":"10.3389\/fped.2022.971073"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejim.2024.02.020","article-title":"TSLP is localized in and released from human lung macrophages activated by T2-high and T2-low stimuli: Relevance in asthma and COPD","volume":"124","author":"Poto","year":"2024","journal-title":"Eur. J. Intern. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaci.2021.05.033","article-title":"TSLP disease-associated genetic variants combined with airway TSLP expression influence asthma risk","volume":"149","author":"Murrison","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.4049\/jimmunol.174.12.8183","article-title":"Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity","volume":"174","author":"Ying","year":"2005","journal-title":"J. Immunol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.4049\/jimmunol.1800709","article-title":"Bronchial Allergen Challenge of Patients with Atopic Asthma Triggers an Alarmin (IL-33, TSLP, and IL-25) Response in the Airways Epithelium and Submucosa","volume":"201","author":"Wang","year":"2018","journal-title":"J. Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02770903.2018.1543435","article-title":"Expression of TSLP and IL-33 receptors on sputum macrophages of asthma patients and healthy subjects","volume":"57","author":"Proboszcz","year":"2020","journal-title":"J. Asthma"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1111\/all.14196","article-title":"TSLP and IL-33 reciprocally promote each other\u2019s lung protein expression and ILC2 receptor expression to enhance innate type-2 airway inflammation","volume":"75","author":"Toki","year":"2020","journal-title":"Allergy"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Pelaia, C., Pelaia, G., Crimi, C., Maglio, A., Gallelli, L., Terracciano, R., and Vatrella, A. (2021). Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094369"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/all.15918","article-title":"Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma","volume":"79","author":"Sverrild","year":"2024","journal-title":"Allergy"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/all.15197","article-title":"Baseline type 2 biomarker levels and response to tezepelumab in severe asthma","volume":"77","author":"Corren","year":"2022","journal-title":"Allergy"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S2213-2600(21)00226-5","article-title":"Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): A double-blind, randomised, placebo-controlled, phase 2 trial","volume":"9","author":"Diver","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"P484","DOI":"10.1016\/j.anai.2025.01.024","article-title":"Real-world effects of tezepelumab on small airway dysfunction in severe refractory asthma","volume":"134","author":"Greig","year":"2025","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/02770903.2024.2409987","article-title":"Short-term Tezepelumab effectiveness in patients with severe asthma: A multicenter study","volume":"62","author":"Carpagnano","year":"2025","journal-title":"J. Asthma"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/02770903.2024.2385973","article-title":"Long-term safety of tezepelumab in patients with asthma: A systematic review and meta-analysis of randomized controlled trials","volume":"62","author":"Qin","year":"2025","journal-title":"J. Asthma"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Portacci, A., Scioscia, G., Dragonieri, S., Aliani, M., Lulaj, E., Montagnolo, F., Magaletti, P., Soccio, P., Salerno, L., and Lacedonia, D. (2025). The impact of tezepelumab therapy on perceived asthma triggers: A multicenter real-life study. J. Asthma, ahead of print.","DOI":"10.1080\/02770903.2025.2495725"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2201193","DOI":"10.1183\/13993003.01193-2022","article-title":"Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma","volume":"61","author":"Gauvreau","year":"2023","journal-title":"Eur. Respir. J."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"e13864","DOI":"10.1111\/cts.13864","article-title":"A first-in-human, single and multiple dose study of lunsekimig, a novel anti-TSLP\/anti-IL-13 NANOBODY\u00ae compound, in healthy volunteers","volume":"17","author":"Deiteren","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"108770","DOI":"10.1016\/j.intimp.2022.108770","article-title":"Liproxstatin-1 alleviates LPS\/IL-13-induced bronchial epithelial cell injury and neutrophilic asthma in mice by inhibiting ferroptosis","volume":"109","author":"Bao","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaci.2013.05.011","article-title":"Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma","volume":"132","author":"Cheng","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Murphy, M.B., Vitale, L., O\u2019Neill, T., Maurer, D.M., Malenchek, L., Crocker, A., Patterson, C., Mills-Chen, L., Saley, V., and Antczak, N.M. (2025). Dual Inhibition of Mast Cells and Thymic Stromal Lymphopoietin Using a Novel Bispecific Antibody, CDX-622. Allergy, ahead of print.","DOI":"10.1111\/all.16509"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2401461","DOI":"10.1183\/13993003.01461-2024","article-title":"A proof-of-mechanism trial in asthma with lunsekimig, a bispecific NANOBODY molecule","volume":"65","author":"Deiteren","year":"2025","journal-title":"Eur. Respir. J."},{"key":"ref_153","first-page":"203","article-title":"Baicalin Attenuates Type 2 Immune Responses in a Mouse Allergic Asthma Model through Inhibiting the Production of Thymic Stromal Lymphopoietin","volume":"186","author":"Zeng","year":"2025","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/imr.12558","article-title":"IL-25 in allergic inflammation","volume":"278","author":"Xu","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12931-023-02509-z","article-title":"IL-25 induces airway remodeling in asthma by orchestrating the phenotypic changes of epithelial cell and fibrocyte","volume":"24","author":"Yao","year":"2023","journal-title":"Respir. Res."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Peng, B., Sun, L., Zhang, M., Yan, H., Shi, G., Xia, Z., Dai, R., and Tang, W. (2022). Role of IL-25 on Eosinophils in the Initiation of Th2 Responses in Allergic Asthma. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.842500"},{"key":"ref_157","first-page":"e148103","article-title":"Epithelial miR-206 targets CD39\/extracellular ATP to upregulate airway IL-25 and TSLP in type 2-high asthma","volume":"6","author":"Zhang","year":"2021","journal-title":"JCI Insight"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jaci.2007.07.051","article-title":"Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma","volume":"120","author":"Ballantyne","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Williams, T.C., Loo, S.L., Nichol, K.S., Reid, A.T., Veerati, P.C., Esneau, C., Wark, P.A.B., Grainge, C.L., Knight, D.A., and Vincent, T. (2022). IL-25 blockade augments antiviral immunity during respiratory virus infection. Commun. Biol., 5.","DOI":"10.1038\/s42003-022-03367-z"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/resp.13711","article-title":"Combined blockade of IL-25, IL-33 and TSLP mediates amplified inhibition of airway inflammation and remodelling in a murine model of asthma","volume":"25","author":"An","year":"2020","journal-title":"Respirology"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1177\/1535370219843827","article-title":"IL-25 contributes to lung fibrosis by directly acting on alveolar epithelial cells and fibroblasts","volume":"244","author":"Xu","year":"2019","journal-title":"Exp. Biol. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/cea.12298","article-title":"Direct comparison of the dynamics of IL-25- and \u2018allergen\u2019-induced airways inflammation, remodelling and hypersensitivity in a murine asthma model","volume":"44","author":"Yao","year":"2014","journal-title":"Clin. Exp. Allergy"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12931-023-02557-5","article-title":"Exogenous IL-25 ameliorates airway neutrophilia via suppressing macrophage M1 polarization and the expression of IL-12 and IL-23 in asthma","volume":"24","author":"Chang","year":"2023","journal-title":"Respir. Res."},{"key":"ref_164","first-page":"8607657","article-title":"Serum Levels of Epithelial-Derived Cytokines as Interleukin-25 and Thymic Stromal Lymphopoietin after a Single Dose of Mepolizumab in Patients with Severe Non-Allergic Eosinophilic Asthma: A Short Report","volume":"2019","author":"Januskevicius","year":"2019","journal-title":"Can. Respir. J."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Palacionyte, J., Januskevicius, A., Vasyle, E., Rimkunas, A., Miliauskas, S., and Malakauskas, K. (2024). Clinical Remission Criteria and Serum Levels of Type 2 Inflammation Mediators during 24 Weeks of Treatment with the Anti-IL-5 Drug Mepolizumab in Patients with T2-High Severe Asthma. Diagnostics, 14.","DOI":"10.3390\/diagnostics14131345"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Tsai, M.L., Tsai, M.K., Tsai, Y.G., Lin, Y.C., Hsu, Y.L., Chen, Y.T., Lin, Y.C., and Hung, C.H. (2023). Montelukast Increased IL-25, IL-33, and TSLP via Epigenetic Regulation in Airway Epithelial Cells. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021227"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.imbio.2017.11.001","article-title":"Macrophages: Their role, activation and polarization in pulmonary diseases","volume":"223","author":"Arora","year":"2018","journal-title":"Immunobiology"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Tsai, M.L., Tsai, Y.G., Lin, Y.C., Hsu, Y.L., Chen, Y.T., Tsai, M.K., Liao, W.T., Lin, Y.C., and Hung, C.H. (2021). IL-25 Induced ROS-Mediated M2 Macrophage Polarization via AMPK-Associated Mitophagy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010003"},{"key":"ref_169","first-page":"203","article-title":"Human Host Defense Peptide LL-37 Suppresses TNFalpha-Mediated Matrix Metalloproteinases MMP9 and MMP13 in Human Bronchial Epithelial Cells","volume":"16","author":"Altieri","year":"2024","journal-title":"J. Innate Immun."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/cea.13766","article-title":"Human beta-defensin-2 suppresses key features of asthma in murine models of allergic airways disease","volume":"51","author":"Pinkerton","year":"2021","journal-title":"Clin. Exp. Allergy"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Borchers, N.S., Santos-Valente, E., Toncheva, A.A., Wehkamp, J., Franke, A., Gaertner, V.D., Nordkild, P., Genuneit, J., Jensen, B.A.H., and Kabesch, M. (2021). Human beta-Defensin 2 Mutations Are Associated with Asthma and Atopy in Children and Its Application Prevents Atopic Asthma in a Mouse Model. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.636061"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2024.02.013","article-title":"Human beta defensin 3 knockdown inhibits the proliferation and migration of airway smooth muscle cells through regulating the PI3K\/AKT signaling pathway","volume":"168","author":"Chen","year":"2024","journal-title":"Mol. Immunol."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/7\/996\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:08:49Z","timestamp":1760033329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/7\/996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":172,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["biom15070996"],"URL":"https:\/\/doi.org\/10.3390\/biom15070996","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}